A first-in-man phase I study of RORgamma agonists for the treatment of cancer

Trial Profile

A first-in-man phase I study of RORgamma agonists for the treatment of cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Apr 2015

At a glance

  • Drugs Retinoic acid receptor gamma agonists (Primary)
  • Indications Cancer
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2015 According to a Lycera media release, this trial is expected to begin in mid-2016.
    • 30 Apr 2015 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016 according to a Lycera Corporation media release.
    • 17 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top